Home/Adcendo/Michael Pehl, MSc
MP

Michael Pehl, MSc

Chief Executive Officer

Adcendo

Therapeutic Areas

Adcendo Pipeline

DrugIndicationPhase
ADCE-D01Soft Tissue SarcomaPhase 1/2